-
Alex Kentsis
- Oct 12, 2023
Laura Schmalbrock
Laura is a hematologist who received her MD from the University of Leipzig. During her residency in Hematology/Oncology at the University Hospital Ulm and Charité Berlin, she used functional genomics to investigate drug resistance mechanisms in AML and multiple myeloma. Currently, she is interested in defining mechanisms of persistence of measurable residual disease (MRD) cells in AML using proteogenomic approaches and how the leukemic niche supports drug resistance in AML.
